Anton Jan Van Zonneveld

Title: Anton Jan Van Zonneveld: Innovator in Gene Therapy

Introduction

Anton Jan Van Zonneveld is a notable inventor based in Herent, Belgium. He has made significant contributions to the field of gene therapy, particularly in the development of nucleic acid delivery vehicles. His work focuses on enhancing and inducing angiogenesis, which is crucial for various medical applications.

Latest Patents

Van Zonneveld holds a patent for "Methods of gene therapy with a DNA sequence encoding NOS - A nucleic acid delivery vehicle for enhancing and/or inducing angiogenesis." This innovative delivery vehicle includes a nucleic acid that encodes a protein capable of increasing nitric oxide production. The vehicle is designed to provide cells with the necessary components to enhance angiogenesis in individuals. The patent also describes a cell that produces this nucleic acid delivery vehicle, utilizing a virus vector selected from adenoviral and adeno-associated viral vectors.

Career Highlights

Throughout his career, Anton Jan Van Zonneveld has been associated with Introgene B.V., where he has contributed to advancing gene therapy technologies. His expertise in the field has positioned him as a key figure in the development of therapeutic methods that leverage nucleic acid delivery systems.

Collaborations

One of his notable collaborators is Stefan Frederik Franciscus Verlingen, with whom he has worked on various projects related to gene therapy and nucleic acid delivery systems.

Conclusion

Anton Jan Van Zonneveld's innovative work in gene therapy exemplifies the potential of nucleic acid delivery vehicles in enhancing medical treatments. His contributions continue to influence the field and pave the way for future advancements.